BlackRock’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$60.2M Buy
6,803,399
+1,349,873
+25% +$11.9M ﹤0.01% 2308
2025
Q1
$42.7M Buy
5,453,526
+14,118
+0.3% +$111K ﹤0.01% 2432
2024
Q4
$57.2M Buy
5,439,408
+182,404
+3% +$1.92M ﹤0.01% 2341
2024
Q3
$68.9M Buy
5,257,004
+440,261
+9% +$5.77M ﹤0.01% 2256
2024
Q2
$67.7M Buy
4,816,743
+4,740,301
+6,201% +$66.6M ﹤0.01% 2225
2024
Q1
$1.29M Sell
76,442
-5,090
-6% -$86K ﹤0.01% 4065
2023
Q4
$1.15M Buy
81,532
+3,047
+4% +$43K ﹤0.01% 4144
2023
Q3
$808K Buy
78,485
+25,101
+47% +$259K ﹤0.01% 4234
2023
Q2
$880K Buy
53,384
+6,185
+13% +$102K ﹤0.01% 4238
2023
Q1
$432K Buy
47,199
+8,881
+23% +$81.4K ﹤0.01% 4480
2022
Q4
$274K Buy
38,318
+4,249
+12% +$30.4K ﹤0.01% 4678
2022
Q3
$171K Buy
34,069
+5,299
+18% +$26.6K ﹤0.01% 4923
2022
Q2
$70K Sell
28,770
-7,936
-22% -$19.3K ﹤0.01% 5247
2022
Q1
$251K Buy
36,706
+6,782
+23% +$46.4K ﹤0.01% 4960
2021
Q4
$242K Buy
29,924
+9
+0% +$73 ﹤0.01% 4993
2021
Q3
$293K Buy
29,915
+5,337
+22% +$52.3K ﹤0.01% 4825
2021
Q2
$165K Sell
24,578
-484,706
-95% -$3.25M ﹤0.01% 4864
2021
Q1
$4.6M Sell
509,284
-74,384
-13% -$672K ﹤0.01% 3917
2020
Q4
$3.9M Buy
+583,668
New +$3.9M ﹤0.01% 3730
2018
Q4
Sell
-483,369
Closed -$2.12M 4904
2018
Q3
$2.12M Sell
483,369
-4,769
-1% -$20.9K ﹤0.01% 3702
2018
Q2
$2.99M Sell
488,138
-24,313
-5% -$149K ﹤0.01% 3574
2018
Q1
$3.74M Sell
512,451
-49,888
-9% -$364K ﹤0.01% 3465
2017
Q4
$4.61M Sell
562,339
-20,915
-4% -$171K ﹤0.01% 3426
2017
Q3
$6.12M Buy
583,254
+57,516
+11% +$604K ﹤0.01% 3352
2017
Q2
$5.8M Sell
525,738
-17,986
-3% -$198K ﹤0.01% 3388
2017
Q1
$5.26M Buy
+543,724
New +$5.26M ﹤0.01% 3335
2015
Q4
Sell
-1,300
Closed -$21K 3402
2015
Q3
$21K Buy
+1,300
New +$21K ﹤0.01% 2323